Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib with Decitabine or Cytarabine in Older AML
NCT02532010Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pacritinib in acute myeloid leukemia (AML), sponsored by Weill Cornell Medicine. Started Jun 2015; status: terminated.
02
Drugs
pacritinib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02532010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532010.